降低PCSK5的调节通过调节STAT3促进了andrographolide对质母细胞瘤的抑制作用
Huiyuan Gong1, Xiaomin Yang1, Lijun An1
1Department of Immunology, Basic Medical College, Guizhou Medical University, No.6, Ankang Road, Guian New District, Guiyang, 550004, Guizhou, People's Republic of China.
Molecular and cellular biochemistry
|March 30, 2024
概括
蛋白转化酶亚提利辛/凯类型5 (PCSK5) 促进了质母细胞瘤 (GBM) 的进展. 结合PCSK5下调和andrographolide,通过向STAT3/MMPs通路来抑制GBM细胞的增殖,入侵和瘤生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白转化酶亚提利辛/凯类型5 (PCSK5) 与细胞迁移和转化有关.
- 安德罗格拉福利德表现出蛋白转化酶 (PC) 抑制和抗瘤特性.
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
研究的目的:
- 调查PCSK5下调和安德罗格拉福利德对GBM进展的联合作用.
- 为了阐明底层的分子机制.
- 评估PCSK5作为GBM的治疗点.
主要方法:
- 癌症基因组图谱 (TCGA) 和临床GBM样本的分析.
- 在GBM细胞中进行PCSK5淘汰实验.
- 在体外检测细胞增殖和侵入的试验.
- 在体内瘤生长研究.
- 西方涂抹用于评估蛋白质表达 (p-STAT3,MMPs).
- 对STAT3信号的药理学操纵.
主要成果:
- 在GBM组织中,PCSK5显著升级,与晚期和不良预后相关.
- PCSK5的敲击减弱了IL-6诱导的上皮层-介质细胞过渡 (EMT) 样性质.
- 结合PCSK5淘汰和Andrographolide治疗可以抑制GBM细胞的增殖,入侵和瘤生长.
- 降低PCSK5的调节会降低p-STAT3和MMPs的表达,这种途径可以被Andrographolide调节.
结论:
- 通过调节p-STAT3/MMPs轴,PCSK5在GBM中起到瘤促进作用.
- 联合安德罗格拉福利德和PCSK5沉默为GBM提供了潜在的治疗策略.
- 准PCSK5为GBM治疗提供了一个有前途的途径.
关键词:
安德罗格拉福利德 (Andrographolide) 是一种色蛋白质.在EMT中,EMT是EMT.质母细胞瘤 (glioblastoma) 是一个在PCSK5中使用.在STAT3/MMPs轴上更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
47
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.2K
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
